大唐药业
(920433)
| 流通市值：11.48亿 | | | 总市值：17.35亿 |
| 流通股本：1.69亿 | | | 总股本：2.56亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 102,317,249.5 | 73,858,902.06 | 45,426,052.56 | 207,449,553.2 |
| 营业收入 | 102,317,249.5 | 73,858,902.06 | 45,426,052.56 | 207,449,553.2 |
| 二、营业总成本 | 150,712,037.99 | 99,538,721.68 | 44,064,489.37 | 202,679,425.51 |
| 营业成本 | 47,129,481.53 | 33,938,167.26 | 16,610,676.04 | 63,236,619.9 |
| 税金及附加 | 2,909,405.6 | 2,809,091.5 | 315,640.09 | 4,765,367.85 |
| 销售费用 | 63,675,966.48 | 39,927,219.1 | 15,867,201.24 | 87,148,533.84 |
| 管理费用 | 30,942,332.77 | 20,241,217.98 | 9,593,947.56 | 36,677,156.2 |
| 研发费用 | 7,074,051.58 | 4,261,025.28 | 1,469,694.17 | 9,473,311.35 |
| 财务费用 | -1,019,199.97 | -1,637,999.44 | 207,330.27 | 1,378,436.37 |
| 其中:利息费用 | -842,861.26 | -1,456,663.05 | 591,546.94 | 1,696,496.5 |
| 其中:利息收入 | 189,439.5 | 187,159.49 | 391,478.28 | 332,891.21 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 205,308.77 | 166,614.41 | 12,937.8 | 123,995.34 |
| 加:投资收益 | 407,051.72 | 308,868.06 | - | 1,827,592.97 |
| 资产减值损失(新) | -3,424,058.06 | -2,099,061.26 | -303,726.79 | -2,761,471.02 |
| 信用减值损失(新) | -1,632,221.07 | -1,069,329.88 | -558,499.03 | -479,014.93 |
| 其他收益 | 4,895,011.9 | 2,862,612.8 | 1,031,718.95 | 8,318,433.47 |
| 四、营业利润 | -47,943,695.23 | -25,510,115.49 | 1,543,994.12 | 11,799,663.52 |
| 加:营业外收入 | 467,605.96 | 246,500 | 110,000 | 1,589,719.19 |
| 减:营业外支出 | - | - | - | 38,080 |
| 五、利润总额 | -47,476,089.27 | -25,263,615.49 | 1,653,994.12 | 13,351,302.71 |
| 减:所得税费用 | -6,398,919.1 | -3,362,384.16 | 365,112.82 | 2,814,808.71 |
| 六、净利润 | -41,077,170.17 | -21,901,231.33 | 1,288,881.3 | 10,536,494 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -41,077,170.17 | -21,901,231.33 | 1,288,881.3 | 10,536,494 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -41,077,170.17 | -21,901,231.33 | 1,288,881.3 | 10,536,494 |
| 扣除非经常损益后的净利润 | -45,860,710.39 | -24,773,680.47 | 575,773.65 | 1,103,693.2 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.16 | -0.09 | 0.01 | 0.04 |
| (二)稀释每股收益 | -0.16 | -0.09 | 0.01 | 0.04 |
| 九、综合收益总额 | -41,077,170.17 | -21,901,231.33 | 1,288,881.3 | 10,536,494 |
| 归属于母公司股东的综合收益总额 | -41,077,170.17 | -21,901,231.33 | 1,288,881.3 | 10,536,494 |
| 公告日期 | 2025-10-29 | 2025-08-27 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |